R B Cameron

Synergistic antitumor effects of combination immunotherapy with recombinant interleukin-2 and a recombinant hybrid alpha-interferon in the treatment of established murine hepatic metastases.

R B Cameron, Joe McIntosh, S A Rosenberg · PubMed · 1988 · 155 citations

Medicine, Immunology, Oncology +17

Synergistic antitumor activity of tumor-infiltrating lymphocytes, interleukin 2, and local tumor irradiation. Studies on the mechanism of action.

R B Cameron, Paul J. Spiess, S A Rosenberg · The Journal of Experimental Medicine · 1990 · 116 citations · Full text

Life Sciences, Immunology, Oncology +17

Effect of combined therapy with lymphokine-activated killer cells, interleukin 2 and specific monoclonal antibody on established B16 melanoma lung metastases.

Avi Eisenthal, R B Cameron, Ingeborg K. Uppenkamp et al. · PubMed · 1988 · 29 citations

Life Sciences, Immunology, Oncology +16

Induction of antibody-dependent cellular cytotoxicity in vivo by IFN-<i>alpha</i> and its antitumor efficacy against established B16 melanoma liver metastases when combined with specific anti-B16 monoclonal antibody.

Avi Eisenthal, R B Cameron, S A Rosenberg · The Journal of Immunology · 1990 · 27 citations · Full text

Life Sciences, Immunology, Oncology +16

A randomised, double‐blind, placebo‐controlled study of the <scp>LAG</scp>‐3‐depleting monoclonal antibody <scp>GSK2831781</scp> in patients with active ulcerative colitis

Geert D’Haens, Laurent Peyrin‐Biroulet, Daniel JB Marks et al. · Alimentary Pharmacology & Therapeutics · 2023 · 12 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17